We are pleased to see the Phase 2b ELEVATE IPF trial of deupirfenidone in #idiopathicpulmonaryfibrosis (IPF) featured in the August issue of The American Journal of Respiratory and Critical Care Medicine (AJRCCM). The manuscript, which was previously published online, reports findings that helped inform the design of the recently initiated Phase 3 SURPASS-IPF trial – the first industry-sponsored head-to-head trial in #IPF, which will assess superiority of deupirfenidone vs. pirfenidone. The August issue also includes an accompanying editorial by Dr. Chad Newton. Read the publication here: https://bit.ly/3SaeykN Read the editorial here: https://bit.ly/4fT71yu   American Thoracic Society #idiopathicpulmonaryfibrosis #IPF

To view or add a comment, sign in

Explore content categories